4-氨基-3-硝基喹啉 | 42606-33-7

• 物质功能分类: 医药中间体 - 喹啉类化合物
• 分子结构分类: 有机化合物 - 有机杂环化合物 - 喹啉及其衍生物
• 中文名称: 4-氨基-3-硝基喹啉
• 英文名称: 3-nitro-4-aminoquinoline
• 英文别名: 4-amino-3-nitroquinoline；3-nitroquinolin-4-amine；3-nitro-quinolin-4-ylamine；3-Nitro-[4]chinolylamin；4-Amino-3-nitro-quinoline
• CAS: 42606-33-7
• 化学式: C₉H₇N₃O₂
• 分子量: 189.173
• InChiKey: SKPRPEJLFKCOAB-UHFFFAOYSA-N

物化性质

• 熔点：
  261-262℃
• 沸点：
  405.3±30.0 °C(Predicted)
• 密度：
  1.445

计算性质

• 辛醇/水分配系数(LogP)：
  1.9
• 重原子数：
  14
• 可旋转键数：
  0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  84.7
• 氢给体数：
  1
• 氢受体数：
  4

安全信息

• 安全说明：
  S24/25
• 海关编码：
  2933499090

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: 4-Amino-3-nitroquinoline
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: 4-Amino-3-nitroquinoline
CAS number: 42606-33-7

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C9H7N3O2
Molecular weight: 189.2

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  4-氨基-3-硝基喹啉 在 钯 氢气 、 原甲酸三甲酯 作用下， 生成 1H-imidazo[4,5-c]quinoline
  参考文献：
  名称：

  新的1H-咪唑并[4,5-c]喹啉-4-胺衍生物作为A3腺苷受体的变构增强剂的构效关系。

  摘要：

  1H-咪唑并[4,5-c]喹啉-4-胺衍生物已被合成为人类A3腺苷受体（AR）的变构调节剂。在4-氨基和2位上进行结构修饰。在结合和功能测定中都测试了该化合物，并且通过几种不同的标准，发现许多化合物是A3AR激动剂作用的变构增强剂。首先，对于许多衍生物，观察到了激动剂C1-IB-MECA的最大功效的增强。同样，许多这些化合物降低了激动剂[125I] I-AB-MECA从A3AR的解离速率。最显着的是，发现化合物43（LUF6000）在功能测定中可将激动剂功效提高45％，并在不影响激动剂效价的情况下类似地降低解离速率。A3AR的变构增强的结构要求不同于抑制平衡结合的要求。因此，我们制备了人A3AR的变构增强剂，其与在正构位点抑制平衡结合相比具有改善的变构作用。

  DOI：

  10.1021/jm060086s
• 作为产物：
  描述：

  3-氨基-4-氯喹啉 在 potassium permanganate 、 氨 作用下， 以73%的产率得到4-氨基-3-硝基喹啉
  参考文献：
  名称：

  Tondyz, Hanna; Plas, Henk C. van der; Wozniak, Marian, Journal of Heterocyclic Chemistry, 1985, vol. 22, p. 353 - 355

  摘要：

  DOI：

文献信息

• Thioether substituted imidazoquinolines
  申请人：——

  公开号：US20030100764A1

  公开（公告）日：2003-05-29

  Imidazoquinoline and tetrahydroimidazoquinoline compounds that contain thioether functionality at the 1-position are useful as immune response modifiers. The compounds and compositions of the invention can induce the biosynthesis of various cytokines and are useful in the treatment of a variety of conditions including viral diseases and neoplastic diseases.

  咪唑喹啉和四氢咪唑喹啉化合物，在1位含有硫醚功能团，可用作免疫反应调节剂。本发明的化合物和组合物能够诱导各种细胞因子的生物合成，并且在治疗包括病毒性疾病和肿瘤性疾病在内的多种病症中有效。
• Amide substituted imidazoquinolines
  申请人：——

  公开号：US20030144283A1

  公开（公告）日：2003-07-31

  Imidazoquinoline and tetrahydroimidazoquinoline compounds that contain amide functionality at the 1-position are useful as immune response modifiers. The compounds and compositions of the invention can induce the biosynthesis of various cytokines and are useful in the treatment of a variety of conditions including viral diseases and neoplastic diseases.

  咪唑喹啉和四氢咪唑喹啉化合物，在1位点含有酰胺功能团，可作为免疫应答调节剂。本发明的化合物和组合物可诱导各种细胞因子的生物合成，并可用于治疗包括病毒性疾病和肿瘤性疾病在内的各种疾病。
• Sulfone substituted imidazo ring ethers
  申请人：Radmer R. Matthew

  公开号：US20070155767A1

  公开（公告）日：2007-07-05

  Imidazo ring compounds (e.g., imidazoquinolines, 6,7,8,9-tetrahydroimidazoquinolines, imidazonaphthyridines, and 6,7,8,9-tetrahydroimidazonaphthyridines) with a sulfide-, sulfinyl-, or sulfonyl-containing ether substituent at the 1-position, pharmaceutical compositions containing the compounds, intermediates, methods of making the compounds, and methods of use of these compounds as immunomodulators, for inducing cytokine biosynthesis in animals and in the treatment of diseases including viral and neoplastic diseases, are disclosed.

  咪唑环化合物（例如咪唑喹啉，6,7,8,9-四氢咪唑喹啉，咪唑萘啉和6,7,8,9-四氢咪唑萘啉）在1-位置具有含硫醚，亚砜基或磺酰基的醚取代基，含有这些化合物的药物组合物，中间体，制备这些化合物的方法，以及将这些化合物用作免疫调节剂的方法，用于诱导动物中的细胞因子生物合成以及治疗包括病毒性和肿瘤性疾病在内的疾病。
• Aryl ether substituted imidazoquinolines
  申请人：——

  公开号：US20030212092A1

  公开（公告）日：2003-11-13

  Imidazoquinoline and tetrahydroimidazoquinoline compounds that contain ether and aryl or alkenyl functionality at the 1-position are useful as immune response modifiers. The compounds and compositions of the invention can induce the biosynthesis of various cytokines and are useful in the treatment of a variety of conditions including viral diseases and neoplastic diseases.

  咪唑喹啉和四氢咪唑喹啉化合物，在1位点含有醚和芳基或烯基功能团，可用作免疫应答调节剂。该发明的化合物和组合物可以诱导各种细胞因子的生物合成，并可用于治疗包括病毒性疾病和肿瘤性疾病在内的各种疾病。
• [EN] N-1 BRANCHED ALKYL SUBSTITUTED IMIDAZO[4,5-C]QUINOLINE COMPOUNDS, COMPOSITIONS, AND METHODS<br/>[FR] COMPOSÉS IMIDAZO[4,5-C]QUINOLÉINE SUBSTITUÉS PAR ALKYLE N-1 RAMIFIÉ, COMPOSITIONS ET PROCÉDÉS
  申请人：3M INNOVATIVE PROPERTIES CO

  公开号：WO2020245706A1

  公开（公告）日：2020-12-10

  Imidazo[4,5-c]quinoline compounds having a substituent that is attached at the N-1 position by a branched group, single enantiomers of the compounds, pharmaceutical compositions containing the compounds, and methods of making the compounds are disclosed. Methods of use of the compounds as immune response modifiers, for inducing (or inhibiting) cytokine biosynthesis in humans and animals, and in the treatment of diseases including infectious and neoplastic diseases are also disclosed.

  本发明公开了在N-1位置通过支链基团连接的Imidazo[4,5-c]喹啉化合物，化合物的单对映体，含有这些化合物的药物组合物，以及制备这些化合物的方法。还公开了将这些化合物用作免疫应答调节剂的方法，用于诱导（或抑制）人类和动物体内的细胞因子生物合成，并用于治疗包括传染性和肿瘤性疾病在内的疾病的方法。